THE ALEX'S LEMONADE STAND FOUNDATION – Trademark Portfolio
Entity Type: 99
THE ALEX'S LEMONADE STAND FOUNDATION holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 41 (Education & Entertainment) — 1 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include SUPERSIBS!. The owner is based in WYNNEWOOD, PA.
333 EAST LANCASTER AVENUE, SUITE 414
WYNNEWOOD, PA 19096
Showing of trademarks Trademarks
Trademark Classifications
THE ALEX'S LEMONADE STAND FOUNDATION's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Education; providing of training; entertainment; sporting and cultural activities
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does THE ALEX'S LEMONADE STAND FOUNDATION have?
THE ALEX'S LEMONADE STAND FOUNDATION has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does THE ALEX'S LEMONADE STAND FOUNDATION file in?
THE ALEX'S LEMONADE STAND FOUNDATION files trademarks across 2 Nice Classification classes. The most active classes are Class 41 (Education & Entertainment), Class 44 (Medical Services). Class 41 covers education; providing of training; entertainment; sporting and cultural activities.
What are THE ALEX'S LEMONADE STAND FOUNDATION's most well-known trademarks?
THE ALEX'S LEMONADE STAND FOUNDATION's registered trademark portfolio includes well-known marks such as SUPERSIBS!. These are among 1 currently registered trademark in the portfolio.
What is THE ALEX'S LEMONADE STAND FOUNDATION's trademark registration success rate?
THE ALEX'S LEMONADE STAND FOUNDATION has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.